ABOUT US

Since Ropack’s founding in 1976 as a two-person organization in 4,000 square feet of rented space to today’s global footprint, our goal has remained the same: to consistently deliver quality and reliability to our clients. Today we operate four state-of-the-art facilities in Montreal, Canada and offer pharmaceutical contract manufacturing and packaging services for all phases of the drug development process.  If you are looking for a strategic partner who stands ready to help you overcome the biggest challenges when bringing your drug to market, give us a call.

Because we have been true to our goal, Ropack Pharma Solutions counts among its client base many of the most-respected organizations in the pharmaceutical and nutraceutical industries

CONTRACT PACKAGING SERVICES

When Time-Reduction, Cost-Savings, Quality And Reliability Matter, Ropack Pharma Solutions Is The Distribution Partner Positioned To Deliver.

As your clinical material partner, we simplify – and accelerate – your clinical trials. From assistance with time-consuming international documentation through destruction following all regulatory protocols, RPS is your trusted clinical trial partner.

Ropack Pharma Solutions is positioned to warehouse and distribute even the most sensitive products.

Ropack Pharma Solutions provides a serialized supply chain that is proficient, verified and ready to safeguard your pharmaceutical product and the patients who depend on it.

Ropack Pharma Solutions is equipped to produce sachets in a range of fills, including powder, liquid/cream and solid dosage fill of one or two different products per sachet.

With ample available capacity, Ropack Pharma Solutions provides the efficiency of five bottling lines with quick changeovers, online validated fill accuracy and the flexibility to accommodate small lots to commercial runs for the bottling of tablets, capsules and powders.

The blending of APIs and excipients to create a homogenous blend is a crucial component in the solid dose and powder dose pharmaceutical manufacturing process. Because blender speed and time are key factors in achieving a uniform mixture, Ropack utilizes gold-standard technology.

Ropack Pharma Solution’s ample, nimble capacity and validated processes bring quality and reliability to encapsulation.

When time-reduction, cost-savings, quality and reliability matter, ropack pharma solutions is the distribution partner positioned to deliver.

The BEC 300, manufactured by Uhlmann, is the eighth and newest blister line at Ropack Pharma Solutions. The single-lane unit integrates blistering, cartoning and serialization. The highly efficient BEC 300, which produces cold formed (alu/alu) and Aclar® blisters at high speeds, will be serialization-ready by May 2017, well ahead of the Drug Supply Chain Security Act (DSCSA) mandate of November 2017.

To complement Ropack Pharma Solutions’ drug development and packaging technologies, we provide clinical and commercial drug manufacturing services for solid oral dosage.

Ropack Pharma Solutions offers a wide variety of clinical trial manufacturing services to the industry, by scientists with Big Pharma experience, utilizing gold-standard technology designed by the most-respected manufacturers in the pharmaceutical industry, such as Glatt and Korsch.

Ropack Pharma Solutions welcomes the challenge of solving complex supply issues by using a unique blend of traditional and innovative services that can significantly shorten timelines, reduce cost and improve drug availability and patient compliance.

Ropack recognizes that the unique design of stick-pack offers multiple benefits – for pharma and natural health products as well as to consumers.

Ropack Pharma Solutions provides encapsulation services for commercial pharmaceutical and natural health products as well as over-encapsulation for clinical application. Our hard gelatin fillers are designed specifically for powder filling and can  accommodate capsule sizes from 3 through 00. Clinical over-encapsulation adjusts for such potential discrepancies as weight, sound and visual differences.

Ropack Pharma Solutions offers turnkey primary and secondary pharmaceutical packaging services of solid oral dosages into blisters, bottles, flip-top vials, stick-packs and sachets.

Easily blended in a child’s food or beverage, pediatric powders in unit-dose stick-packs provide taste masking and convenience without compromising integrity.

Ropack Pharma Solutions offers turnkey contract primary and secondary pharmaceutical packaging services of solid oral dosages. Whether in blisters, bottles, flip-top vials, stick-packs, sachets or strip-packs, we manufacture and package powders, tablets and capsules for clinical or commercial applications.

HVAC Ventilation and AC Systems

Since 1976, our focus at Ropack Pharma Solutions is on bringing our customers' products to market reliably, efficiently and competitively. Our culture of innovation and continuous improvement allows us to provide a broad spectrum of pharmaceutical and nutraceutical services, from early-stage solid oral dosage drug formulation through clinical manufacturing and packaging as well as commercial manufacturing and packaging.  We bring solutions to even the most complex challenges.

We recognize the importance of secondary packaging to an Rx, OTC or natural health product’s potency, efficacy and shelf life, so we provide solutions that are practical and reliable.

CONTACT INFORMATION

Ropack Pharma Solutions

10801 Mirabeau St.

Montreal, QC H1J 1T7

CANADA

Phone: 514.353.7000 ext. 2272

Fax: 514-353-7211

Contact: Christopher Vounasis

FEATURED ARTICLES

  • In this Q&A we dig into some of the essential elements our experts identify as key to maintaining and enhancing both existing and new partnerships. Learn how outsourcing this key aspect of bringing product to market can benefit your organization and overall supply chain optimization.

  • Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. The pharmaceutical manufacturing industry has witnessed a significant increase in the number of drug approvals by the FDA over the past few years leading to several packaging innovations. Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

  • As the COVID-19 pandemic continues, it is important to understand the expectations of regulators about how to facilitate paper-based facility inspections in lieu of those performed on site.

  • There is growing interest among consumers in verifying that the dietary supplements they take are safe and efficacious. The concern over whether consumers are getting the product as it is described on the label is rooted in one vital and transformative fact: probiotics are living organisms that are highly sensitive to humidity and oxygen. In the absence of proper handling and packaging, the efficacy of probiotic products can be compromised at any point of the packaging, storage and transportation process, inversely impacting shelf life and product viability and efficacy for the consumer.

  • Determine your plan now for serialization readiness to put the worries of DSCSA costs and timelines behind you and patient safety back where it belongs — at the forefront.

  • The FDA’s intent to not enforce the requirements of the Drug Supply Chain Security Act until November 2018 offered an additional year meet compliance. The deadline for that grace period is now!

  • When asked about the biggest challenges to the pharmaceutical company sponsor-contract service provider relationship, sponsors and service providers offer pretty consistent responses.  

  • Determining a drug candidate’s probability of commercial success is a most significant phase in the drug development process. There is no room for error.

  • Using QRM gives a company the ability to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.

  • An effective quality agreement communicates the responsibilities of each party in a clear, concise manner, allowing the reader to quickly and accurately determine to whom a specific responsibility is assigned. 

  • A pharmaceutical contract services organization encounters many compounds at different phases of development and varying customer requirements. From fully developed large scale manufacturing and packaging to a single development batch, the contract services organization must be prepared to handle multiple compounds in the same facility.

  • As with the pharma industry, packagers are challenged to grow through innovation, by providing formats which satisfy pharma's expectation of enhanced drug integrity, safety, and stability while delivering the convenience demanded by today's consumer.

  • Quality metrics have been widely used in the pharma industry to monitor quality systems, operational processes, and to promote continuous improvement initiatives in drug manufacturing. 

  • A contract packaging partner should function as an extension of the pharma’s organization, so careful consideration should be devoted to initiating this relationship. 

  • Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. The pharmaceutical manufacturing industry has witnessed a significant increase in the number of drug approvals by the FDA over the past few years leading to several packaging innovations. Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

  • Understanding the FDA audit process, preparing for it and being aware of regulations will help to restore a sense of control and help to ensure the best outcome.

  • Emerging countries offer a nearly untapped opportunity. Despite the opportunities, these markets also hold unique challenges. Blister packaging effectively addresses these challenges.

  • Trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market. 

  • This regulation from the FDA outlined serialization and traceability requirements spread over the course of 10 years with preparation for each phase accumulating into a potentially high overall price tag.

  • A contact packaging leader outfits its new facility with a new stick packaging line, giving pharmaceutical and nutraceutical companies another way to ease product use. By Ropack, Inc.

VIDEOS

  • Ropack provides contract bottle filling of HDPE, PET, glass and flip-top vial bottles for tablets, capsules, soft/liquid gels and powders. With a bottling capacity of 20 million and 12 million for flip-top vials, Ropack brings the efficiency of five bottling lines with quick changeovers, on-line validated fill accuracy and the flexibility to accommodate small lots to commercial runs.

  • Ropack provides encapsulation services of solid oral dosage to the pharmaceutical, natural health product and food supplement industries in cGMP, FDA and Health Canada regulated production suites.

  • Ropack, Your Trusted Packaging Partner provides a number of pouch and sachet filling services for powder, solid, liquid, and other dosage types. Pouch and Sachet filling under nitrogen and pouch filling in a controlled-humidity environment are also available.

  • Ropack provides a number of blister packaging services and can produce blister packaging in several different forms, including regular thermo-form, cold-formed, and heat-sealed blister cards.

  • Ropack offers turnkey primary and secondary pharmaceutical packaging services of solid oral dosages, tablets, powder, and encapsulation into blisters, pouches, bottles, carded blisters and syringe assembly. Our facilities are cGMP compliant and FDA certified. Ropack is competitive, flexible and agile; supporting clinical trials, short run start-ups, commercial production and warehousing and distribution services for over 100 U.S., Canadian and European pharmaceutical and nutraceutical customers.

  • Ropack, Your Trusted Packaging Partner provides Stick-Pack Packaging. Stick-packs offer consumers the convenience and flexibility their active lives demand. An ideal format for pediatric and geriatric formulations. Stick-packs offer consumers the convenience and flexibility their active lives demand. An ideal format for pediatric and geriatric formulations.

  • Ropack, Your trusted packaging partner produces exact filling of HDPE, PET and Glass bottles. Bottles are sealed with induction seals, permaseals, and child-resistant or senior-friendly caps.

  • Ropack, Your Trusted Packaging Partner provides in-Canada clinical trial distribution reduces costs and shortens go-to-market timelines while ensuring accuracy and the highest level of security.

  • Ropack's in-Canada clinical trial distribution reduces costs and shortens go-to-market timelines while ensuring accuracy and the highest level of security. When pharmas and CROs send bulk product, Ropack purchases components in country and eliminates the governmental red tape and associated cost of shipping from out of country.

  • Contract packaging for pharmaceutical and consumer health-care is Ropack's core service. Global customers rely on our exacting production environments — 32 Class 100000 Clean Rooms, including a dedicated facility ensuring low RH and controlled temperature. With four production facilities totaling nearly 250,000 square feet, Ropack has ample capacity, state-of-the-industry technology and the flexibility to provide stability and commercial production in short and long runs.